TW200528433A - Novel compounds - Google Patents

Novel compounds Download PDF

Info

Publication number
TW200528433A
TW200528433A TW093136389A TW93136389A TW200528433A TW 200528433 A TW200528433 A TW 200528433A TW 093136389 A TW093136389 A TW 093136389A TW 93136389 A TW93136389 A TW 93136389A TW 200528433 A TW200528433 A TW 200528433A
Authority
TW
Taiwan
Prior art keywords
disorders
tetrahydro
methyl
methoxy
chlorobenzyloxy
Prior art date
Application number
TW093136389A
Other languages
English (en)
Chinese (zh)
Inventor
David Clapham
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of TW200528433A publication Critical patent/TW200528433A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
TW093136389A 2003-11-28 2004-11-26 Novel compounds TW200528433A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0327740.7A GB0327740D0 (en) 2003-11-28 2003-11-28 Novel compounds

Publications (1)

Publication Number Publication Date
TW200528433A true TW200528433A (en) 2005-09-01

Family

ID=29798028

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093136389A TW200528433A (en) 2003-11-28 2004-11-26 Novel compounds

Country Status (18)

Country Link
US (1) US20070275948A1 (cg-RX-API-DMAC7.html)
EP (1) EP1687279A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007512285A (cg-RX-API-DMAC7.html)
KR (1) KR20060103322A (cg-RX-API-DMAC7.html)
CN (1) CN1906170A (cg-RX-API-DMAC7.html)
AR (1) AR046719A1 (cg-RX-API-DMAC7.html)
AU (1) AU2004293179A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0417029A (cg-RX-API-DMAC7.html)
CA (1) CA2547444A1 (cg-RX-API-DMAC7.html)
GB (1) GB0327740D0 (cg-RX-API-DMAC7.html)
IL (1) IL175663A0 (cg-RX-API-DMAC7.html)
IS (1) IS8500A (cg-RX-API-DMAC7.html)
MA (1) MA28177A1 (cg-RX-API-DMAC7.html)
NO (1) NO20062970L (cg-RX-API-DMAC7.html)
RU (1) RU2006122959A (cg-RX-API-DMAC7.html)
TW (1) TW200528433A (cg-RX-API-DMAC7.html)
WO (1) WO2005051916A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200603781B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0510599D0 (en) * 2005-05-24 2005-06-29 Glaxo Group Ltd Novel compounds
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
EP2240466B1 (en) * 2008-01-08 2015-07-29 Merck Sharp & Dohme Limited Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamide
US20180228811A1 (en) * 2014-12-12 2018-08-16 The Schepens Eye Research Institute, Inc. Gdnf induction for the treatment of retinal disorders
CN110446495B (zh) 2017-02-17 2023-09-05 特维娜有限公司 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
US12297184B2 (en) 2018-10-03 2025-05-13 Tesaro, Inc. Niraparib salts
CN116406268A (zh) * 2020-10-27 2023-07-07 特维娜有限公司 δ-阿片样物质调节剂的结晶和无定形形式
CN115998724B (zh) * 2023-03-28 2023-06-16 中国人民解放军军事科学院军事医学研究院 布洛芬在抗幻觉作用药物中的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1456178A1 (en) * 2001-12-21 2004-09-15 Smithkline Beecham Plc 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
PL371344A1 (en) * 2002-02-13 2005-06-13 Glaxo Group Limited Benzenesulfonamide derivatives as antipsychotic agents
MY133587A (en) * 2002-05-29 2007-11-30 Glaxo Group Ltd Aromatic sulfones and their medical use

Also Published As

Publication number Publication date
WO2005051916A1 (en) 2005-06-09
CN1906170A (zh) 2007-01-31
US20070275948A1 (en) 2007-11-29
EP1687279A1 (en) 2006-08-09
JP2007512285A (ja) 2007-05-17
IS8500A (is) 2006-06-08
AR046719A1 (es) 2005-12-21
ZA200603781B (en) 2007-09-26
MA28177A1 (fr) 2006-09-01
AU2004293179A1 (en) 2005-06-09
IL175663A0 (en) 2006-09-05
CA2547444A1 (en) 2005-06-09
RU2006122959A (ru) 2008-01-10
GB0327740D0 (en) 2003-12-31
BRPI0417029A (pt) 2007-02-06
NO20062970L (no) 2006-08-21
KR20060103322A (ko) 2006-09-28

Similar Documents

Publication Publication Date Title
CN1805938B (zh) 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
TW201004939A (en) Novel compounds
JP5287257B2 (ja) アシルグアニジン誘導体
TW200305423A (en) N-carbamoyl nitrogen-containing condensed ring compound and medicament containing same as active ingredient
BR112017023088B1 (pt) Compostos agonistas do receptor 5-ht2c, composição farmacêutica,seu processo de preparação e seus usos
TW200418846A (en) Substituted benzoxazinones and uses thereof
TWI289141B (en) Quinolinone derivatives and uses thereof
EA039412B1 (ru) 5-ht2c рецепторные агонисты и композиции и способы применения
TW200806657A (en) Compounds which have activity at M1 receptor and their uses in medicine
MXPA04007920A (es) Derivados de bencensulfonamida como agentes antisicoticos.
JP5747910B2 (ja) ベンゾアゼピン化合物
TWI236469B (en) Diamine compound with condensed-ring groups
JP2007512285A (ja) 抗精神病薬としての7−[4−(4−クロロベンジルオキシ)ベンゼンスルホニル]−8−メトキシ−3−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピニウムマレエートもしくはトシレート
TW200901979A (en) Compounds which have activity at M1receptor and their uses in medicine
TWI354555B (en) Substituted spirobenzazepines
TW200817322A (en) Compounds having activity at the GlyT1 transporter
CA1263385A (en) 1-phenyl-3-benzazepines
TWI303246B (en) Fused ring nk1 antagonists
JP2005531580A (ja) 抗精神病薬としての7−フェニルスルホニル−テトラヒドロ−3−ベンゾアゼピン誘導体
JP2010523525A (ja) 早漏症の治療のためのピリジノン誘導体
JP2008542222A (ja) マレイン酸ベンゾアゼピニウム誘導体の結晶形
TW200530188A (en) Novel compounds
US20250289805A1 (en) N-heterocycle substituted tryptamine derivatives and methods of using
JPS62238271A (ja) 1−フエニル−3−ベンズアゼピン類
MXPA06006077A (en) 7-[4-(4 -chlorobenzyloxy) benzenesulfonyl]-8-methoxy -3-methyl-2, 3, 4, 5-tetrahydro -1h-3- benzazepinium maleate or tosylate as antipsychotics